SRx Health Solutions Statistics
 Total Valuation
 SRXH has a market cap or net worth of $8.76 million. The enterprise value is $46.22 million.
 Important Dates
 The next estimated earnings date is Friday, November 14, 2025, after market close.
 | Earnings Date | Nov 14, 2025 | 
| Ex-Dividend Date | n/a | 
Share Statistics
 SRXH has 24.85 million shares outstanding.
 | Current Share Class | 24.85M | 
| Shares Outstanding | 24.85M | 
| Shares Change (YoY) | n/a | 
| Shares Change (QoQ) | n/a | 
| Owned by Insiders (%) | 52.92% | 
| Owned by Institutions (%) | 1.26% | 
| Float | 11.70M | 
Valuation Ratios
  | PE Ratio | n/a | 
| Forward PE | n/a | 
| PS Ratio | 0.04 | 
| Forward PS | n/a | 
| PB Ratio | n/a | 
| P/TBV Ratio | n/a | 
| P/FCF Ratio | 5.72 | 
| P/OCF Ratio | 3.06 | 
| PEG Ratio | n/a | 
 Financial Ratio HistoryEnterprise Valuation
  | EV / Earnings | n/a | 
| EV / Sales | 0.39 | 
| EV / EBITDA | n/a | 
| EV / EBIT | n/a | 
| EV / FCF | 30.21 | 
Financial Position
 The company has a current ratio of 0.38
 | Current Ratio | 0.38 | 
| Quick Ratio | 0.28 | 
| Debt / Equity | n/a | 
| Debt / EBITDA | n/a | 
| Debt / FCF | 25.85 | 
| Interest Coverage | -4.26 | 
Financial Efficiency
  | Return on Equity (ROE) | n/a | 
| Return on Assets (ROA) | -10.96% | 
| Return on Invested Capital (ROIC) | -20.97% | 
| Return on Capital Employed (ROCE) | 883.51% | 
| Revenue Per Employee | $268,968 | 
| Profits Per Employee | -$25,187 | 
| Employee Count | 444 | 
| Asset Turnover | 2.38 | 
| Inventory Turnover | 19.45 | 
Taxes
 In the past 12 months, SRXH has paid $197,376 in taxes.
 | Income Tax | 197,376 | 
| Effective Tax Rate | n/a | 
Stock Price Statistics
 The stock price has decreased by -79.28% in the last 52 weeks.
 | Beta (5Y) | n/a | 
| 52-Week Price Change | -79.28% | 
| 50-Day Moving Average | 0.35 | 
| 200-Day Moving Average | 0.98 | 
| Relative Strength Index (RSI) | 53.03 | 
| Average Volume (20 Days) | 545,176 | 
Short Selling Information
 The latest short interest is 503,074, so 2.02% of the outstanding shares have been sold short.
 | Short Interest | 503,074 | 
| Short Previous Month | 2.08M | 
| Short % of Shares Out | 2.02% | 
| Short % of Float | 4.30% | 
| Short Ratio (days to cover) | 0.25 | 
Income Statement
 In the last 12 months, SRXH had revenue of $119.42 million and -$11.18 million in losses. Loss per share was -$0.90.
 | Revenue | 119.42M | 
| Gross Profit | 23.71M | 
| Operating Income | -8.79M | 
| Pretax Income | -10.99M | 
| Net Income | -11.18M | 
| EBITDA | -7.08M | 
| EBIT | -8.79M | 
| Loss Per Share | -$0.90 | 
 Full Income StatementBalance Sheet
 The company has $2.08 million in cash and $39.54 million in debt, giving a net cash position of -$37.47 million or -$1.51 per share.
 | Cash & Cash Equivalents | 2.08M | 
| Total Debt | 39.54M | 
| Net Cash | -37.47M | 
| Net Cash Per Share | -$1.51 | 
| Equity (Book Value) | -6.32M | 
| Book Value Per Share | -0.50 | 
| Working Capital | -40.53M | 
 Full Balance SheetCash Flow
 In the last 12 months, operating cash flow was $2.86 million and capital expenditures -$1.28 million, giving a free cash flow of $1.53 million.
 | Operating Cash Flow | 2.86M | 
| Capital Expenditures | -1.28M | 
| Free Cash Flow | 1.53M | 
| FCF Per Share | $0.06 | 
 Full Cash Flow StatementMargins
 Gross margin is 19.85%, with operating and profit margins of -7.36% and -9.36%.
 | Gross Margin | 19.85% | 
| Operating Margin | -7.36% | 
| Pretax Margin | -9.20% | 
| Profit Margin | -9.36% | 
| EBITDA Margin | -5.93% | 
| EBIT Margin | -7.36% | 
| FCF Margin | 1.28% | 
Dividends & Yields
 SRXH does not appear to pay any dividends at this time.
 | Dividend Per Share | n/a | 
| Dividend Yield | n/a | 
| Dividend Growth (YoY) | n/a | 
| Years of Dividend Growth | n/a | 
| Payout Ratio | n/a | 
| Buyback Yield | n/a | 
| Shareholder Yield | n/a | 
| Earnings Yield | -127.72% | 
| FCF Yield | 17.47% | 
 Analyst Forecast
  | Price Target | n/a | 
| Price Target Difference | n/a | 
| Analyst Consensus | n/a | 
| Analyst Count | n/a | 
| Revenue Growth Forecast (5Y) | n/a | 
| EPS Growth Forecast (5Y) | n/a | 
 Fair Value
 There are several formulas that can be used to estimate the intrinsic value of a stock.
 | Lynch Fair Value | n/a | 
| Lynch Upside | n/a | 
| Graham Number | n/a | 
| Graham Upside | n/a | 
Stock Splits
 This stock does not have any record of stock splits.
 | Last Split Date | n/a | 
| Split Type | n/a | 
| Split Ratio | n/a | 
Scores
 SRXH has an Altman Z-Score of 0.26 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
 | Altman Z-Score | 0.26 | 
| Piotroski F-Score | 2 |